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1. General	  
 All chemicals and solvents purchased from Sigma-Aldrich were used without further 
purification. Spectra of 1H NMR and 13C NMR were recorded using a Bruker DPX-400 in 
CDCl3 with TMS as internal reference. Splitting in the spectra are shown as s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), and br (broad). 
 Absorption spectrometry was performed using a Varian spectrophotometer. Steady 
state fluorescence measurements were conducted using a Varian Eclipse spectrofluorometer. 
Column chromatography of all products was performed using Merck Silica Gel 60 (particle 
size: 0.040–0.063 mm, 230–400 mesh ASTM). Reactions were monitored by thin layer 
chromatography using fluorescent coated aluminum sheets. Solvents used for spectroscopy 
experiments were spectrophotometric grade. Mass spectra were recorded on Agilent 
Technologies 6530 Accurate-Mass Q-TOF LC/MS.  
The following equation was used for quantum yield calculation,  
 
                     Q = QR (I/IR)(AR/A) x (n2/nR2)      Equation 1 
 
where QR is the quantum yield of the reference compound (cresyl violet, 0.78), I and IR are 
the integrated areas of the emission spectra for sample and reference, respectively; A and AR 
represent absorbance values at the excitation wavelength (610 nm) for sample and standard 
assuming a path length of 1 cm; and n and nR refer to refractive indices of the solvents in 
which the sample and standard compounds were dissolved, respectively. 
FRET efficiency was determined using the formula below:  
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                                         E = 1- φF(DA)/φF(D)   Equation 2 
 
where φF(D) and φF(DA) refer to fluorescence quantum yields donor (D) alone and donor as a 
part of EET system respectively.   
 
2. Additional Figures 
 
Scheme S1. Chemical Structures of PS and Quencher (Q) modules 
 
 
Figure S1. Normalized electronic absorption spectra of compounds 1 (black), 2 (red), 3 (blue) 
and 4 (green) in their neutral (solid) and protonated (dash) forms. Measurements are done in 
water for compounds 1 and 2 whereas 40% THF in water was used for others. 
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Table S1. Summary of protonation dependent absorbance change of compounds 1-5 and 
BOD1 and their experimental pKa values.a 
Compound λ1[nm] λ2[nm] pKa
b 
1 615 594 3.42 
2 601 723 4.21 
3 626 628 -b 
4 660 636 2.62 
5 649 731 6.62 
PSc 649 730 6.92 
 
a λ1 corresponds to maximum absorbance wavelength of compounds in neutral solutions 
whereas λ2 corresponds to the value of fully protonated compounds. Values are measured in 
water for compounds 1, 2, 5 and BOD 1 and in 40% THF in water for compounds 3 and 4. b 
pKa cannot be determined due to decomposition at high pH. c Micellar form of the PS part of 
BOD 1 is used to determine the pKa value of PS in water. 
 
Figure S2. Normalized electronic absorption spectra of neutral (solid) and deprotonated 
(dash) forms of compounds 5 (red), and micellar form of PS module of BOD 1 (black) in 
40% THF/water and water respectively. Wavelength of excitation (625 nm) used for PDT 
measurements is indicated with blue dashed line. 
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Table S2.  Photophysical characterization of BOD 1, PS and Quencher.a 
Compound λ1,abs[nm] λ2, emm[nm] ε  (M-1cm-1) φΦ 
PS 645 
720b 
667 
- 
40000 
30000 b 
0.13 
- 
Quencher 685 
685b 
707 
- 
57000 
63000b 
0.76 
- 
BOD 1 640, 685 
687b 
654, 707 
707b 
42000c, 56000d 
70000b 
0.24 
0.15 
 
a Values are determined in THF. bpiperidine is used as a base additive. ccalculated for 
absorption at 640 nm. dcalculated for absorption at 685 nm. 
 
 
 
Figure S3. pH dependent change in the ratio of absorbance of PS in Cremophor EL micelle at 
730 nm with respect to absorbance at 649 nm in water. 
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Figure S4. Comparison of normalized emission of PS module (black, solid) and absorption of 
Quencher module (red, dash) in THF depicting an excellent overlap for electronic energy 
transfer. 
 
 
Figure S5. Electronic absorption spectra of neutral (black) and deprotonated (red) forms of 
micellar BOD 1 in water (a), and comparison of fluorescence spectra of equally absorbing 
micellar PS (red, dash) and BOD 1 (black, solid) in water (b, excited at 625 nm).  
 
 
S7 
 
 
 
 
 
 
Figure S6. The cleavage of quencher from the photosensitizer in BOD 1 after incubation 
with GSH for 12 h as analyzed by HRMS, (Δ = 8.8 ppm for Q-Q disulphide quencher, Δ = 
4.65 ppm for thiol photosensitizer). PS-GSH adduct (M+Na-2H)- and thiol quencher (M-F)- 
were detected in micelle free samples.  
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Figure S7. Emission spectra of micellar BOD 1 at the time of addition of 2.5 equivalents of 
GSH (black, solid) and after 12h incubation with glutathione (red, dash) in water. The 
spectrum is taken by excitation at 625 nm. 
 
 
 
Figure S8. Excitation spectrum of micellar BOD 1 in water for emission at 715 nm. 
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Figure S9. Control experiment with the solution containing the trap molecule only in acidic 
(black) and basic (red) acqueous conditions 
 
 
 
 
3. Experimental Details 
 
pKa Determination. Aqueous solutions of each compound are prepared and titrated with 
aliquots of acid (HCl) and base (NaOH) solutions. Each time, pH of the solution is measured 
with the aid of a pH meter and the spectra are recorded.Since there are two different absorbing 
species, one protonated/deprotonated and one neutral, two different peak absorbance 
wavelengths are observed. Plotting pH versus the ratio of absorbance at these two 
wavelengths and subsequent non-linear curve fit in Origin software gives the experimental 
pKa values in water. For some compounds 3, 4 and PS 40% THF was used to increase 
solubility. Since PS is the true module of the target compound (BOD 1) and is not soluble in 
water, the pKa measurements are performed after the formation of micelle.  
 
Micelle Preparation. Micelles of PS module are prepared with Cremophor EL using the 
procedure in literature.i 50 mg Cremophor EL and PS (6 mg, 5 µmol) or BOD 1 (14 mg, 5 
µmol) are dissolved in 330 ml freshly distilled tetrahydrofuran. The solution is sonicated for 
30 min, while the sonication water bath is kept below 35oC. Then, THF is evaporated under 
reduced pressure and the remaining compounds are dissolved in water (5 ml). The suspension 
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is filtered through 0.45 µm PTFE filter. For each measurement micelles are prepared freshly. 
Concentrations of solutions of the compounds in micelles are predicted using their extinction 
coefficients in THF. GSH (2.5 equivalent) is added to the solution of BOD 1 before the 
preparation of the micelle and the sample is incubated at room temperature for 12 h at room 
temperature, before HRMS and spectroscopic analysis are performed.  
 
1O2 Generation Experiments. 1O2 dependent degradation of water soluble trap, 2,2'-
(anthracene-9,10-diylbis(methylene) dimalonic acid is used to measure photodynamic activity 
since the absorption of this compound decreases upon reaction indicating the generation of 
1O2.ii Since the water solubility of the anthracene-based trap is poor in water, samples are 
sonicated for 15 min to obtain clear solutions. Measurements are performed using 625 nm 
LED and samples are irradiated with the light source from a 5 cm distance. All samples are 
aerated for 5 min prior to experiments. After incubation under dark for 15 min, light is 
irradiated for 60 min and UV-Vis spectra are recorded at each 5 min intervals. Relative singlet 
oxygen efficiency is calculated by the percent decrease in trap absorbance at 378 nm within 
60 min light irradiation period.  
 
4. Synthesis 
 
 
Synthesis of Compound S3: Compound S1iii (120 mg, 0.19 mmol) and 4-
pyridinecarboxaldehyde (51 mg, 0.48 mmol) were dissolved in benzene (40 ml). Piperidine 
(0.4 ml) and acetic acid (0.4 ml) were added. The reaction mixture was refluxed using Dean 
Stark apparatus until all aldehyde was consumed. After the reaction was completed, it was 
extracted with CHCl3 and water. Organic layer was collected and dried with Na2SO4, 
evaporated under reduced pressure. The product was purified by silica gel column 
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chromatography using CHCl3/MeOH (95:5, v/v). Fraction containing compound S3 was 
collected then the solvent was removed under reduced pressure (0.09 mmol, 75 mg, 49%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.69 (4, 2H, J = 6.0 Hz; CH), 8.08 (d, 2H, J = 16.7 Hz; 
ArH), 7.84 (d, 2H, J = 16.7 Hz; CH), 7.50 (d, 4H, J = 6.0 Hz; ArH), 7.22 (d, 2H, J = 8.4 Hz; 
ArH), 7.18 (d, 2H, J = 8.4 Hz; ArH), 4.81 (d, 2H, J = 2.4 Hz; OCH2), 2.60 (t, 1H, J = 2.4 Hz; 
OCH2CH), 1.50 (s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 158.8, 150.3, 149.9, 147.1, 143.7, 141.4, 136.6, 133.9, 
129.3, 127.5, 122.8, 121.5, 116.2, 83.7, 77.7, 76.2, 56.1, 17.8.  
HRMS (TOF-ESI): m/z calcd for C34H25BF2I2N4O: 809.0252 [M+H]+; found: 809.0290 
[M+H]+, Δ = 4.70 ppm. 
 
Synthesis of Compound 1: Compound S3 (50 mg, 62 µmol) and azide functionalized 
polyethylene glycol monomethylether (2000MW, 124 mg, 62 µmol) were dissolved in 
tetrahydrofuran (2 ml). Triethylamine (430 µl) and CuI (24 mg, 0.126 mmol) were added. The 
reaction mixture was stirred for 12 h at room temperature. After the reaction was completed, it 
was extracted with CHCl3 and brine. The organic layer was collected and dried over Na2SO4, 
followed by evaporation of the solvent under reduced pressure. The product was purified by 
silica gel column chromatography using CHCl3/MeOH (95:5, v/v) as mobile phase. Fraction 
containing compound 1 was collected then the solvent was removed under reduced pressure 
(34 µmol, 100 mg, 54%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.62 (4H; CH), 8.04 (d, 2H, J = 16.72 Hz; CH), 7.80 (d, 
2H, J = 16.80 Hz; CH), 7.51 (d, 2H, J = 5.52 Hz; ArH), 7.19 (2H + 2H; ArH), 5.25 (2H; 
OCH2), 4.58 (t, 2H, J = 5.08 Hz; NCH2), 3.90-3.30 (PEG, OCH2CH2O), 1.50 (s, 6H; ArCH3). 
 
Synthesis of Compound S5iv: 2,6-lutidine (5 g, 47 mmol) was dissolved in 60 ml acetone. m-
chloroperbenzoic acid (13 g, 75 mmol) was dissolved in 60 ml acetone and was added to 
previous mixture dropwise during the course of 10 minutes. The reaction mixture was stirred 
for 90 min. at room temperature. Then, it was cooled using an ice bath for 30 min. Following 
this, 20 ml of ice cold diethyl ether was added and HCl gas was bubbled through the reaction 
for 10 min. The solid produced as a result of bubbling was filtered, washed two times with 
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ether. Then, salt was dissolved in 20 ml of water; pH was adjusted to be above 10 using 
NaHCO3. Finally, the solution was extracted with CHCl3, solvent was evaporated to yield 
liquid colorless compound S5 (40 mmol, 4.9 g, 85%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.18 (d, 2H, J = 7.24 Hz; ArH), 7.00 (t, 1H, J = 7.56 Hz; 
ArH), 2.45 (s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 148.7, 124.4, 123.8, 18.1. 
 
Synthesis of Compound S6: Compound S5 (6 g, 32 mmol) was dissolved in 100 ml 
dichloromethane. Equal amount of trimethyloxonium tetrafluoroborate (32 mmol, 7.05 g) was 
added and the reaction mixture was stirred for 5h at RT. Solvent was was vacuum evaporated 
to yield a white solid (quantitative, used without further purification).  
1H NMR (D2O, 400 MHz, δ ppm) 8.18 (t, 1H, J = 7.92 Hz; ArH), 7.75 (d, 2H, J = 7.96 Hz; 
ArH), 4.22 (s, 3H; OCH3), 2.81 (s, 6H; ArCH3). 
13C NMR (D2O, 400 MHz, δ ppm) 153.6, 143.8, 128.0, 66.6, 16.7. 
 
Synthesis of Compound S7: Compound S6 (5.19 g, 23.1 mmol) was dissolved in 65 ml 
MeOH. Potassium peroxodisulfate (1.53 g, 5.65 mmol) was dissolved in 6 ml H2O and was 
added to previous reaction mixture. The solution was refluxed for 30 min while it was 
irradiated with light. Following this, more of potassium peroxodisulfate (3.06 g, 11.30 mmol) 
was added and the resction was refluxed for additional 30 min. The excess K2S2O2 was 
filtered off and the solvent was vacuum evaporated to yield brown oil. The product was 
further purified by column chromatography using CHCl3:MeOH (90/10; v/v) as mobile phase 
(yellow oil, 0.86 g, 6.3 mmol, 27%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.48 (s, 2H; ArH), 4.91 (s, 1H; CH2OH), 2.60 (s, 6H; 
ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 161.6, 152.5, 121.1, 61.5, 18.5. 
 
Synthesis of Compound S8v: Compound S7 (864 mg, 6.3 mmol) was dissolved in 2.5 ml 
CHCl3 and 1 ml methanol. The solution was heated to 35oC to dissolve the compound. Then, 
1.1 equivalents of MnO2 (0.61 g, 7 mmol) was added at RT. After stirring 2h at RT, additional 
amount of MnO2 (0.51 g) was added. After 2h, the solid precipitates were removed by 
filtering over celite. The solvent was removed by vacuum evaporation. Then the product was 
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prufied further by precipitation of the impurities in CHCl3. (white solid, 101 mg, 0.75 mmol, 
12%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 9.93 (s, 1H), 7.30 (s, 2H; ArH), 2.53 (s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 192.1, 159.5, 124.1, 119.0, 24.3.  
 
Synthesis of Compound S9: Compound S1 (93 mg, 0.15 mmol) and 2,6-dimethyl-4-
pyridinecarboxaldehyde (S8, 60 mg, 0.44 mmol) were dissolved in benzene (15 ml). 
Piperidine (0.4 ml) and acetic acid (0.4 ml) were added. The reaction mixture was refluxed 
using Dean Stark apparatus until all aldehyde was consumed. After the reaction was 
completed, it was extracted with CHCl3 and water. Organic layer was collected and dried with 
Na2SO4, evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using CHCl3/MeOH (95:5, v/v) as mobile phase. Fraction containing 
compound S9 was collected, then the solvent was removed under reduced pressure (0.07 
mmol, 61 mg, 47%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.00 (d, 2H, J = 16.73 Hz; CH), 7.78 (d, 2H, J = 16.69 
Hz; CH), 7.21 (d, 2H, J = 8.80 Hz; ArH), 7.18 (d,s, 2H + 1H, J = 8.91 Hz; ArH), 4.81 (d, 2H, 
J = 2.36 Hz; OCH2), 2.6 (s, 12H, ArCH3), 2.5 (1H, CH), 1.52 (s, 6H, ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 158.3, 150.1, 147.0, 144.4, 141.1, 137.2, 133.8, 129.3, 
127.5, 122.3, 118.8, 118.4, 116.2, 105.9, 77.8, 76.2, 56.1, 24.1, 17.7.  
HRMS (TOF-ESI): m/z calcd for C38H34BF2I2N4O+: 865.0878 [M+H]+, found: 865.07406 
[M+H]+, Δ = 1.59 ppm. 
 
Synthesis of Compound 2: Compound S9 (42 mg, 49 µmol) and azide functionalized 
polyethylene glycol monomethylether (2000MW, 84 mg, 62 µmol) were dissolved in 
tetrahydrofuran (2 ml) and water (0.1 ml). Triethylamine (50 µl) was added and the reaction 
was stirred for 5 min. Then, CuSO4.5H2O (4 mg, 29 µmol) and sodium ascorbate (6 mg, 29 
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µmol) were added. The reaction mixture was stirred for 12 h at room temperature. After the 
reaction was completed, it was extracted with CHCl3 and brine. The organic layer was 
collected and dried over Na2SO4, followed by evaporation of the solvent under reduced 
pressure. The product was purified by silica gel column chromatography using CHCl3/MeOH 
(92:8, v/v) as mobile phase. Fraction containing compound 2 was collected then the solvent 
was removed under reduced pressure (6 µmol, 18 mg, 12%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 8.00 (d, 2H, J = 16.73 Hz; ArH), 7.96 (s, 1H; ArH), 7.81 
(d, 2H, J = 16.76 Hz; ArH), 7.25-7.15 (m, 2H + 2H + 4H; ArH), 5.29 (s, 2H; OCH2), 4.12 (t, 
2H, J = 4.72 Hz; NCH2), 2.60 (s, 12H; ArCH3), 1.52 (s, 6H; ArCH3). 
HRMS (TOF-ESI): Distribution around 2800 with separation of 44 corresponding to etylene 
glycole unit. 
 
Synthesis of Compound S11vi: 2,6-dichloronicotinic acid (500 mg, 2.6 mmol) was dissolved 
in 5.2 ml MeOH. 78 µl concentrated H2SO4 was added. The reaction mixture was refluxed for 
1h. Then, the reaction was cooled to RT and was quenched with NaHCO3. It was extracted 
with CHCl3 and water. The organic layer was collected and dried over Na2SO4, followed by 
evaporation of the solvent under reduced pressure. The product was purified by silica gel 
column chromatography using CHCl3 as mobile phase. Fraction containing compound S11 
was collected then the solvent was removed under reduced pressure (white solid, 2.4 mmol, 
490 mg, 92%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.84 (s, 2H; ArH), 4.01 (s, 3H; OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 163.2, 151.5, 142.4, 122.6, 53.3. 
 
Synthesis of Compound S12: Compound S11 (250 mg, 1.21 mmol) was dissolved in 10 ml of 
anhydrous dimethylformamide. Ar was purged in the solution for 15 min. Potassium 
methoxide (255 mg, 3.64 mmol, 864 µl) was added to the reaction mixture and it was refluxed 
for 12h. Then, the reaction mixture was neutralized with HCl solution. It was extracted with 
CHCl3 and water. The organic layer was collected and dried over Na2SO4, followed by 
evaporation of the solvent under reduced pressure. The product was purified by silica gel 
column chromatography using CHCl3/Hexanes (3/2; v/v) as mobile phase. Fraction containing 
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compound S12 was collected then the solvent was removed under reduced pressure (white 
solid, 0.51 mmol, 100 mg, 42%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 6.87 (s, 2H; ArH), 3.96 (s, 6H; ArOCH3), 3.92 (s, 3H; 
OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 165.6, 163.8, 142.7, 101.2, 53.9, 52.5. 
 
Synthesis of Compound S13: Compound S12 (800 mg, 4.06 mmol) and 2 equivalents of 
NaBH4 (309 mg, 8.12 mmol) were dissolved in 10 ml dioxane. It was refluxed for 1h. Then, 
the reaction was cooled to RT and quenched with ice cold water. It was extracted with 
CH2Cl2. The organic layer was collected and dried over Na2SO4, followed by evaporation of 
the solvent under reduced pressure (686 mg, quantitative).  
1H NMR (CDCl3, 400 MHz, δ ppm) 6.30 (s, 2H, ArH), 4.62 (s, 2H; ArCH2), 3.91 (s, 6H; 
ArOCH3), 1.93 (b, 1H; ArCH2OH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 163.5, 155.6, 98.3, 63.8, 53.6. 
 
Synthesis of Compound S14: Compound S13 (172 mg, 1.02 mmol) was dissolved in 6 ml of 
CHCl3. 1.1 equivalents of MnO2 (98 mg, 1.12 mmol) was added, and the reaction mixture was 
stirred at RT for 12 h. After completion of the reaction as followed by thin layer 
chromatography, the reaction mixture was filtered over celite to get rid of MnO2 by products. 
Solvent was removed under reduced pressure to yield compound S14 (yellow solid, 118 mg, 
68%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.94 (s, 1H), 6.73 (s, 2H; ArH), 4.00 (s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 191.2, 164.3, 147.5, 100.7, 54.0. 
HRMS (TOF-ESI): m/z calcd for C8H10NO3+: 168.0655 [M+H]+, found:168.06143 [M+H]+, Δ 
= 2.42 ppm. 
 
Synthesis of Compound 16: Hydroquinone (2 g, 18.2 mmol) was dissolved in 30 ml acetone. 
5 equivalents of K2CO3 (12.6 g, 91 mmol) was added and the reaction mixture was refluxed 
for 30 min. Then, 3 equivalents of propargyl bromide (6. 48 g, 54.6 mmol) was added 
dropwise. The reaction mixture was refluxed for additional 12 h. Then, it was  cooled to RT. 
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Following the extraction with CHCl3, the organic layer was collected and dried over Na2SO4, 
followed by evaporation of the solvent under reduced pressure. Crude product was 
crystallized in hexanes to yield compound S16 (white solid, quantitative).  
1H NMR (CDCl3, 400 MHz, δ ppm) 6.94 (s, 2H; ArH), 4.67 (d, 4H, J = 2.44 Hz; ArOCH2), 
2.53 (t, 2H, J = 2.44 Hz; CCH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 152.4, 116.0, 78.8, 75.4, 56.5. 
 
Synthesis of Compound S18: CH2Cl2 (300 ml) was purged with Ar for 30 min. Compound 
S17 (1.1 g, 4.45 mmol) and 2,4-dimethyl pyrrole (0.96 ml, 9.4 mmol) were added. The color 
of the solution turned into red after the addition of 3 drops of trifluoroacetic acid. The reaction 
mixture was stirred at room temperature for 12h. Then, tetrachloro-1,4-benzoquinone (1.09 g, 
4.45 mmol) was added and the reaction mixture was stirred at room temperature for 45 min. 
Then triethyl amine (5 ml) and boron trifluoride diethyl etherate (5 ml) were added 
sequencially. After stirring at room temperature for 30 min, it was extracted with water. 
Organic layer was dried with Na2SO4 and evaporated under reduced pressure. The product 
was purified by silica gel column chromatography using CHCl3. Fraction containing compound 
S18 was collected then the solvent was removed under reduced pressure (400 mg, 0.86 mmol, 
19% ). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.20 (d, 2H, J = 8.60 Hz; ArH), 7.01 (d, 2H, J = 8.64 Hz; 
ArH), 6.00 (s, 2H; ArH),  4.05 (t, 2H, J = 6.44 Hz; OCH2), 3.31 (t, 2H, J = 6.80 Hz; NCH2), 
2.58 (s, 6H; ArCH3), 1.86 (m, 2H; CH2), 1.70 (m, 2H; CH2), 1.55 (m, 4H; CH2), 1.45 (s, 6H; 
ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 159.6, 155.2, 143.2, 141.9, 131.9, 129.2, 126.9, 121.1, 
115.1, 67.9, 51.4, 29.1, 28.8, 26.6, 25.7, 14.6, 14.5. 
 
Synthesis of Compound S19: Compound S18 (270 mg, 0.58 mmol) and I2 (368 mg, 1.45 
mmol) were dissolved in ethanol (100 ml). Iodic acid, HIO3 (204 mg, 1.16 mmol) was 
dissolved in a few drops of water and added into previous solution. The reaction mixture was 
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stirred at 60oC for a few hours untill all reeactant was consumed. Then, saturated sodium 
thiosulfate solution was added (50 ml) and it was stirred at rrom temparature for additional 30 
min. Then, it was extracted with CHCl3 and water. Organic layer was dried with Na2SO4 and 
evaporated under reduced pressure (415 mg, quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.22 (d, 2H, J = 8.68 Hz; ArH), 7.02 (d, 2H, J = 8.68 Hz; 
ArH), 4.04 (t, 2H, J = 6.36 Hz; OCH2), 3.30 (t, 2H, J = 6.80 Hz; NCH2), 2.63 (s, 6H; ArCH3), 
1.85 (m, 2H; CH2), 1.70 (m, 2H; CH2), 1.55 (m, 4H; CH2), 1.45 (s, 6H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.1, 156.6, 145.5, 141.6, 131.8, 129.1, 126.6, 115.5, 
85.8, 68.0, 51.4, 29.1, 28.8, 26.6, 25.7, 17.2, 16.0.  
HRMS (TOF-ESI): m/z calcd for C25H27BF2I2N5O-: 716.03716 [M-H]-, found: 716.06297 [M-
H]-, Δ = 36.0 ppm. 
 
Synthesis of Compound S20: Compound S16 (519 mg, 2.8 mmol) and compound S19 (200 
mg, 0.28 mmol) were dissolved in CHCl3 (3 ml) and THF (3 ml). Triethylamine (200 µl) was 
added and the reaction was stirred for 5 min. Then, saturated solutions of CuSO4.5H2O (200 
µl) and sodium ascorbate (200 µl) were added. Catalytic amount of Cu (0) was added. The 
reaction mixture was stirred for 12 h at room temperature. After the reaction was completed, it 
was extracted with CHCl3 and organic layer was evaporatd under reduced pressure. It was 
purified by silica gel column chromatography using CHCl3 as mobile phase. Fraction 
containing compound S20 was collected then the solvent was removed under reduced 
pressure (0.27 mmol, 241 mg, 96%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.60 (s, 1H; ArH), 7.21 (d, 2H, J = 8.12 Hz; ArH), 7.02 
(d, 2H, J = 8.17 Hz; ArH), 6.93 (s, 4H; ArH), 5.16 (s, 2H; OCH2), 4.62 (d, 2H, J = 1.52 Hz; 
OCH2), 4.48 (t, 2H, J = 7.12 Hz; NCH2), 4.01 (t, 2H, J = 6. 28 Hz; OCH2), 2.63 (s, 6H; 
ArCH3), 2.02 (t, 1H, J = 1.40 Hz; CH), 1.96 (m, 2H, CH2), 1.82 (m, 2H, CH2), 1.55 (m, 2H, 
CH2), 1.44 (s, m, 6H + 2H, ArCH3 + CH2).   
13C NMR (CDCl3, 400 MHz, δ ppm) 160.0, 156.5, 153.1, 152.1, 145.4, 144.4, 141.7, 131.7, 
129.1, 126.6, 122.5, 116.1, 115.8, 115.4, 78.8, 75.4, 67.9, 62.7, 56.5, 50.3, 30.2, 29.0, 26.3, 
25.6, 17.2, 16.0.  
HRMS (TOF-ESI): m/z calcd for C37H38BF2I2N5NaO3+: 926.1017 [M+Na]+, found: 
926.08227 [M+Na]+, Δ = 20.98 ppm. 
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Synthesis of Compound S21: Compound S20 (125 mg, 0.14 mmol) and 2,6-dimethoxy-4-
pyridinecarboxaldehyde (S14, 92 mg, 0.56 mmol) were dissolved in benzene (30 ml). 
Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture was refluxed 
using Dean Stark apparatus until all aldehyde was consumed. After the reaction was 
completed, it was extracted with CHCl3 and water. Organic layer was collected and dried with 
Na2SO4, evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using CHCl3 as mobile phase. Fraction containing compound S21 was 
collected, then the solvent was removed under reduced pressure (62 µmol, 75 mg, 44%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.94 (d, 2H, J = 16.68 Hz; CH), 7.72 (d, 2H, J = 16.64 
Hz; CH), 7.59 (s, 1H; ArH), 7.16 (d, 2H, J = 8.57 Hz; ArH), 7.04 (d, 2H, J = 8.64 Hz; ArH), 
6.93 (s, 4H; ArH), 6.57 (s, 4H; ArH), 5.20 (s, 2H, OCH2), 4.65 (d, 2H, J = 2.44 Hz; OCH2), 
4.41 (t, 2H, t, J = 7.12 Hz; NCH2), 4.04 (t, 2H, J = 6.32 Hz; OCH2), 3.98 (s, 12H, OCH3), 2.52 
(t, 1H, J = 2.42 Hz; CH), 2.01 (m, 2H, CH2), 1.85 (m, 2H, CH2), 1.62 (s, 6H; ArCH3), 1.48 
(m, 4H; CH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 163.8, 160.21, 153.1, 152.2, 150.0, 149.0, 146.7, 144.5, 
137.2, 133.8, 129.3, 128.3, 126.6, 122.4, 122.3, 116.1, 115.8, 115.5, 99.3, 78.8, 75.4, 67.9, 
62.8, 56.5, 53.7, 50.3, 30.2, 29.0, 26.3, 25.6, 17.8. 
HRMS (TOF-ESI): m/z calcd for C53H52BF2I2N7NaO7+: 1224.1971 [M+Na]+, found: 
1224.1762 [M+Na]+, Δ = 17.07 ppm. 
 
Synthesis of Compound 3: Compound S21 (17 mg, 14 µmol) and azide functionalized 
polyethylene glycol monomethylether (2000MW, 31 mg, 16 µmol) were dissolved in CHCl3 
(1 ml) and THF (1 ml). Triethylamine (50 µl) was added and the reaction was stirred for 5 
min. Then, saturated solutions of CuSO4.5H2O (150 µl) and sodium ascorbate (150 µl) were 
added. Catalytic amount of Cu (0) was added. The reaction mixture was stirred for 12 h at 
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room temperature. After the reaction was completed, the crude product was applied to silica 
gel column chromatography using CHCl3/MeOH (90:10, v/v) as mobile phase. Fraction 
containing compound 3 was collected then the solvent was removed under reduced pressure 
(8 µmol, 26 mg, 58%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 7.96 (d, 2H, J = 16.72 Hz; CH), 7.83 (s, 1H; ArH), 7.73 
(d, 2H, J = 16.64 Hz; CH), 7.62 (s, 1H; ArH), 7.17 (d, 2H, J = 8.76 Hz; ArH), 7.05 (d, 2H, J = 
8.28 Hz; ArH), 6.93 (s, 4H; ArH), 6.54 (s, 4H; ArH), 5.19 (s, 2H; OCH2), 5.17 (s, 2H; OCH2), 
4.58 (t, 2H, J = 5.00 Hz; NCH2), 4.41 (t, 2H, t, J = 7.64 Hz; NCH2), 4.10-3.30 (PEG), 2.01 (m, 
2H, CH2), 1.85 (m, 2H, CH2), 1.62 (s, 6H; ArCH3), 1.48 (m, 4H; CH2).  
HRMS (TOF-ESI): Distribution around 3000 with separation of 44 corresponding to etylene 
glycole unit. 
 
Synthesis of Compound S23vii: 4-methylquinone (1.32 ml, 10 mmol) was dissolved in 1,4-
dioxane (12 ml). Selenium dioxide (1.12 g, 10.12 mmol) was added to the reaction mixture 
and it was refluxed for 8h. Then, solvent was removed under reduced pressure and the crude 
product was applied to silica gel column chromatography using ethyl acetate as mobile phase. 
Fraction containing compound S23 was collected, then the solvent was removed under 
reduced pressure (946 mg, 6 mmol, 60%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 10.50 (s, 1H), 9.19 (d, 1H, J = 4.24 Hz; ArH), 9.00 (dt, 
1H, J1 = 0.64 Hz, J2 = 7.03 Hz; ArH), 8.21 (dt, 1H, J1 = 0.36 Hz, J2 = 7.24 Hz; ArH), 7.70-
7.85 (m, 3H,; ArCH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 192.8, 150.4, 149.3, 136.7, 130.2, 130.0, 129.4, 125.8, 
124.4, 123.8.  
HRMS (TOF-ESI): m/z calcd for C10H8NO+: 158.0600 [M+Na]+, found: 158.05593 [M+Na]+, 
Δ = 25.75 ppm. 
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Synthesis of Compound S24: Compound S20 (91 mg, 0.1 mmol) and quinoline-4-
carboxaldehyde, compound S23 (40 mg, 0.25 mmol) were dissolved in benzene (25 ml). 
Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture was refluxed 
using Dean Stark apparatus until all aldehyde was consumed. After the reaction was 
completed, it was extracted with CHCl3 and water. Organic layer was collected and dried with 
Na2SO4, evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using EtOAc as mobile phase. Fraction containing compound S24 was 
collected, then the solvent was removed under reduced pressure (84 µmol, 99 mg, 84%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.01 (d, 2H, J = 4.64 Hz; ArH), 8.96 (d, 2H, J = 16.56 
Hz; CH), 8.32 (d, 2H, J = 8.40 Hz; ArH), 8.18 (d, 2H, J = 8.36 Hz; ArH), 7.94 (d, 2H, J = 
16.53 Hz; CH), 7.81 (d, 2H, J = 4.60 Hz; ArH), 7.77 (t, 2H, 7.48 Hz; ArH), 7.62 (t, 2H, j = 
7.76 Hz; ArH), 7.22 (d, 2H, J = 8.41 Hz, ArH), 7.09 (d, 2H, J = 8.44 Hz; ArH), 6.95 (s, 4H; 
ArH), 5.20 (s, 2H; OCH2), 4.64 (d, 2H, J = 2.04 Hz; OCH2), 4.43 (t, 2H, J = 7.12 Hz; NCH2), 
4.05 (t, 2H, J = 6.17 Hz; OCH2), 2.52 ( t, 1H, J = 1. 84 Hz; CH), 2.02 (m, 2H; CH2), 1.88 (m, 
2H, CH2), 1.60 (m, 8H, ArCH3 + CH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 163.8, 160.2, 153.1, 152.2, 150.0, 149.0, 146.7, 144.5, 
137.2, 133.8, 129.3, 128.3, 126.6, 122.4, 122.3, 116.1, 115.8, 115.5, 99.3, 78.8, 75.4, 67.9, 
62.8, 56.5, 53.7, 50.3, 30.2, 29.0, 26.3, 25.6, 17.8.  
HRMS (TOF-ESI): m/z calcd for C57H48BF2I2N7NaO3+: 1204.1861 [M+Na]+, found: 
1204.1620 [M+Na]+, Δ = 20.01 ppm. 
 
Synthesis of Compound 4: Compound S24 (20 mg, 17 µmol) and azide functionalized 
polyethylene glycol monomethylether (2000MW, 37 mg, 19 µmol) were dissolved in CHCl3 
(2 ml) and THF (2 ml). Triethylamine (150 µl) was added and the reaction was stirred for 5 
min. Then, saturated solutions of CuSO4.5H2O (250 µl) and sodium ascorbate (250 µl) were 
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added. Catalytic amount of Cu (0) was added. The reaction mixture was stirred for 12 h at 
room temperature. After the reaction was completed, the crude product was applied to 
octadecyl functionalized silica gel column chromatography using CHCl3 as mobile phase. The 
mobile phase was changed to CH2Cl2/MeOH (80:20; v/v) after the starting compound was 
eluted from the column.  Fraction containing compound 4 was collected then the solvent was 
removed under reduced pressure (13 µmol, 40 mg, 76%).  
1H NMR (CDCl3, 400 MHz, δ ppm) 9.02-8.9 (m, 2H + 2H; ArH), 8.31 (d, 2H, J = 8.17 Hz; 
ArH), 8.17 (d, 2H, J = 8.16 Hz; ArH), 7.93 (d, 2H, J = 16.85 Hz; ArH), 7.85-7.70 (m, 2H + 
2H + 1H; ArH), 7.60 (s + d, 1H + 2H; J = 8.24 Hz; ArH), 7.20 (d, 2H, J = 8.16 Hz; ArH), 7.09 
(d, 2H, J = 8.37 Hz; ArH), 6.92 (s, 4H, ArH), 5.16 (s, 2H; OCH2), 5.13 (s, 2H; OCH2),  4.54 
(t, 2H, J = 4.76 Hz; NCH2), 4.40 (t, 2H, J = 6.92 Hz; NCH2), 3.90-3.30 (PEG), 2.00 (m, 2H; 
CH2), 1.85 (m, 2H; CH2), 1.40 (m, 4H; CH2), 1.30 (s, 6H; ArCH3).  
HRMS (TOF-ESI): Distribution around 3000 with separation of 44 corresponding to etylene 
glycole unit. 
 
Synthesis of Compound S26viii: 4-hydroxybenzaldehyde (1.22 g, 10 mmol) was dissolved in 
20 ml acetonitrile. Acetic acid (10 ml) and nitric acid (0.75 ml) were added and the reaction 
was refluxed for 3h. Then, it was cooled to RT and extracted with EtOAc and water. Organic 
layer was collected and dried with Na2SO4, solvent was evaporated under reduced pressure. 
(9.1 mmol, 1.52 g, 91%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 11.05 (s, 1H; ArOH), 9.98 (s, 1H), 8.68 (s, 1H, ArH), 
8.17 (d, 1H, J = 8.61 Hz; ArH), 7.34 (d, 1H, J = 8.68 Hz; ArH). 
13C NMR (CDCl3, 400 MHz, δ ppm) 188.7, 159.3, 136.4, 128.6, 126.2, 121.3, 115.7.  
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Synthesis of Compound PS: Compound S20 (200 mg, 0.22 mmol) and 4-hydroxy-3-
nitrobenzaldehyde, compound S26 (110 mg, 0.66 mmol) were dissolved in benzene (20 ml). 
Piperidine (0.3 ml) and acetic acid (0.3 ml) were added. The reaction mixture was refluxed 
using Dean Stark apparatus until all aldehyde was consumed. After the reaction was 
completed, it was extracted with CH2Cl2 and water. Organic layer was collected and dried 
with Na2SO4, evaporated under reduced pressure. The product was purified by silica gel 
column chromatography using EtOAc as mobile phase. After the impurities are eluted from 
the column, the mobile phase was changed to CH2Cl2/MeOH/AcOH (90/5/5; v/v). Fraction 
containing compound PS was collected, then the solvent was removed under reduced pressure 
(0.15 mmol, 180 mg, 68%). 
1H NMR (PS + AcOH: CDCl3, 400 MHz, δ ppm) 8.79 (s, 2H; ArH), 8.19 (d, 2H, J = 16.81 
Hz; ArH), 7.97 (d, 2H, J = 8.80 Hz; ArH), 7.60 (d + s, 2H + 1H, J = 16.65 Hz; ArH), 7.23 (d, 
2H, J = 8.80 Hz; ArH), 7.19 (d, 2H, J = 7.44 Hz; ArH), 7.05 (d, 2H, J = 8.24 Hz; ArH), 6.93 
(s, 4H; ArH), 5.20 (s, 2H; OCH2), 4.64 (s, 2H; OCH2), 4.41 (t, 2H, J = 7.12 Hz; NCH2), 4.05 
(t, 2H, J = 5.84 Hz; OCH2), 2.52 (s, 1H; CH), 1.85 (m, 2H, CH2), 1.60-1.40 (m, 12H, CH2 + 
ArCH3).  
13C NMR cannot be recorded due to poor solubility.   
HRMS (TOF-ESI): m/z calcd for C51H43BF2I2N7O9- 1200.1278 [M-H]-, found: 1200.13078 
[M-H]-, Δ = 2.48 ppm. 
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Synthesis of Compound S27: Compound S1 (127 mg, 0.2 mmol) and azide functionalized 
polyethylene glycol monomethylether (2000MW, 800 mg, 0.4 mmol) were dissolved in 
tetrahydrofuran (2 ml). Triethylamine (1.4 ml) and CuI (77 mg, 0.4 mmol) were added. The 
reaction mixture was stirred for 12 h at room temperature. After the reaction was completed, 
the crude product was purified by silica gel column chromatography using CHCl3/MeOH 
(93:7, v/v) as mobile phase. Fraction containing compound S27 was collected then the solvent 
was removed under reduced pressure (red oil, 0.11 mmol, 300 mg, 55%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.93 (s, 1H, ArH), 7.12 (b, 2H + 2H), 5.24 (s, 2H; 
OCH2), 4.58 (t, J = 4.84 Hz; NCH2), 3.90-3.40 (PEG), 3.35 (s, 3H; OCH3), 2.60 (s, 6H; 
ArCH3), 1.40 (s, 6H; ArCH3).  
HRMS (TOF-ESI): Distribution around 2500 with separation of 44 corresponding to etylene 
glycole unit. 
 
Synthesis of Compound 5: Compound S27 (120 mg, ~45 µmol) and compound S26 (23 mg, 
135 µmol) were dissolved in benzene (25 ml). Piperidine (0.2 ml) and acetic acid (0.2 ml) 
were added. The reaction mixture was refluxed using Dean Stark apparatus until all aldehyde 
was consumed. After the reaction was completed, the crude product was purified by silica gel 
column chromatography using CH2Cl2/MeOH (85/15; v/v) as mobile phase. Fraction 
containing compound 5 was collected, then the solvent was removed under reduced pressure 
(30 µmol, 90 mg, 66%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.24 (s, 2H; ArH), 8.06 (d, 2H, J = 16.72 Hz; ArH), 7.93 
(m, 2H + 2H; ArH), 7.56 (d, 2H, J = 16.69 Hz; ArH), 7.20 (m, 2H + 2H + 2H; ArH), 5.28 (s, 
2H, OCH2), 4.60 (t, 2H, J = 4.36 Hz; NCH3), 3.90-3.40 (PEG), 3.35 (s, 3H; OCH3), 1.50 (s, 
6H; ArCH3). 
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13C NMR (CDCl3, 400 MHz, δ ppm) 159.6, 155.8, 149.8, 146.7, 143.2, 140.4, 136.2, 135.3, 
133.7, 129.5, 127.2, 124.5, 124.4, 120.7, 119.3, 115.9, 94.3, 83.6, 72.0, 70.6, 69.6, 62.2, 59.0, 
50.7, 50.4, 17.7.  
HRMS (TOF-ESI): Distribution around 2800 with separation of 44 corresponding to etylene 
glycole unit. 
 
Synthesis of Compound S29ix: mercaptoethanol (5 g, 64 mmol) was dissolved in DMSO (20 
ml). The reaction mixture was stirred at 80oC for 12h. Then, it was cooled to RT and was 
extracted with brine and EtOAc. Organic layer was collected and dried with Na2SO4, 
evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using Hexanes/EtOAc 75/25; v/v) as mobile phase. Fraction containing 
compound s9 was collected, then the solvent was removed under reduced pressure (29 mmol, 
4.5 g, 86%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 3.90 (t, 4H, J = 5.84 Hz; OCH2), 7.30 (t, 4H, J = 5.88 Hz; 
SCH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 60.4, 41.3.  
 
Synthesis of Compound S30160: 2-hydroxyethyldisulfide, compound S29 (1 g, 6.5 mmol) was 
dissolved in 20 ml CH2Cl2 and 2 ml Et3N. In a dropper, p-toluene sulfonyl chloride (1.44 g, 
13 mmol) was dissolved in CH2Cl2 10 ml and was added to the previous solution dropwise 
while the reaction mixture was being cooled with ice bath. It was stirred for 12h. After the 
extraction with water, organic layer was collected and dried with Na2SO4, evaporated under 
reduced pressure. The product was purified by silica gel column chromatography using CHCl3 
as mobile phase. Fraction containing compound S30 was collected, then the solvent was 
removed under reduced pressure (white solid, 6.5 mmol, 3 g, quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.83 (d, 4H, J = 8.04 Hz; ArH), 7.38 (d, 4H, J = 7.93 Hz; 
ArH), 4.21 (t, 4H, J = 6.61 Hz; OCH2), 2.85 (t, 4H, J = 6.53 Hz; SCH2), 2.48 (s, 6H, ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 145.2, 130.0, 128.0, 67.5, 36.9, 21.7.   
HRMS (TOF-ESI): m/z calcd for C18H22NaO6S4+ 485.0191 [M+Na]+, found: 485.0104 
[M+Na]+, Δ = 17.94 ppm. 
Synthesis of Compound S31: Compound S30 (1.2 g, 2.6 mmol) was dissolved in 10 ml 
DMSO and sodium azide (12 mmol, 780 mg) was added to the reaction mixture. It was stirred 
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2h at 60 oC. After cooling to RT, it was extracted with EtOAc. Organic layer was collected 
and dried with Na2SO4, evaporated under reduced pressure. (yellow oil, 2.47 mmol, 0.5 g, 
95%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 3.63 (t, 4H, J = 6.76 Hz; NCH2), 2.89 (t, 4H, J = 6.76 Hz; 
SCH2). 
13C NMR (CDCl3, 400 MHz, δ ppm) 49.9, 37.6.  
 
Synthesis of Compound S33: 4-hydroxybenzaldehyde (4 g, 33 mmol), 2-ethylhexyl bromide 
(6.7 ml, 36 mmol) and catalytic amount of benzo-18-crown-6 were dissolved in 60 ml 
acetonitrile. K2CO3 (13.6 g, 98 mmol) was added and the reaction mixture was refluxed for 12 
h. The solvent was evaporated under reduced pressure and the crude product was extracted 
with CH2Cl2. Organic layer was collected and dried with Na2SO4, evaporated under reduced 
pressure. (yellow oil, 7.7 g, quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.88 (s, 1H), 7.83 (d, 2H, J = 8.24 Hz; ArH), 7.01 (d, 2H, 
J = 8.33 Hz; ArH), 3.94 (d, 2H, J = 5.64 Hz; OCH2), 1.77 (m, 1H; CH), 1.45 (m, 4H; CH2), 
1.32 (m, 4H; CH2), 0.93 (m, 6H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 190.7, 164.5, 131.9, 129.7, 114.8, 70.9, 39.3, 30.4, 29.0, 
23.8, 23.0, 14.0, 11.1. 
HRMS (TOF-ESI): m/z calcd for C15H23O2+ 235.16926 [M+H]+, found: 235.17327 [M+H]+, 
Δ = 17.1 ppm. 
 
Synthesis of Compound S34: CH2Cl2 (400 ml) was purged with Ar for 30 min. Compound  
S33 (2.4 g, 10.24 mmol) and 2,4-dimethyl pyrrole (2.3 ml, 22.53 mmol) were added. The 
color of the solution turned into red after the addition of 3 drops of trifluoroacetic acid. The 
reaction mixture was stirred at room temperature for 12 h. Then, tetrachloro-1,4-
benzoquinone (2.52 g, 10.24 mmol) was added and the reaction mixture was stirred at room 
temperature for 1 h. Then triethyl amine (9 ml) and boron trifluoride diethyl etherate (9 ml) 
were added sequencially. After stirring at room temperature for 1 h, it was extracted with 
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water. Organic layer was dried with Na2SO4 and evaporated under reduced pressure. The 
product was purified by silica gel column chromatography using CHCl3 and then 
EtOAc/Hexanes (20/80; v/v) as mobile phase. Fraction containing compound S34 was collected 
then the solvent was removed under reduced pressure (810 mg, 1.8 mmol, 18%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.17 (d, 2H, J = 8.76 Hz; ArH), 7.01 (d, 2H, j = 8.80 Hz; 
ArH), 5.99 (s, 2H; ArH), 3.92 (d, 2H, J = 5.93 Hz, OCH2), 2.55 (s, 6H, ArCH3), 1.79 (m, 1H, 
CH), 1.60-1.40 (m, s, 4H + 6H; CH2 + ArCH3), 1.37 (m, 4H; CH2), 0.96 (m, 6H, CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.0, 155.2, 143.2, 142.1, 131.9, 129.1, 126.8, 121.1, 
114.8, 70.9, 39.4, 30.6, 29.1, 23.9, 23.0, 14.6, 14.1, 11.2.  
 
Synthesis of Compound S35: Compound S34 (330 mg, 0.73 mmol) and I2 (389 mg, 1.53 
mmol) were dissolved in ethanol (200 ml). Iodic acid, HIO3 (256 mg, 1.46 mmol) was 
dissolved in a few drops of water and added into previous solution. The reaction mixture was 
stirred at 60oC for 1 h untill all reeactant was consumed. Then, saturated sodium thiosulfate 
solution was added (50 ml) and it was stirred at room temparature for additional 30 min. 
Then, it was extracted with CHCl3 and water. Organic layer was dried with Na2SO4 and 
compound S35 was obtained by evaporation of the solvent under reduced pressure (514 mg, 
quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.12 (d, 2H, J = 8.68 Hz; ArH), 7.03 (d, 2H, j = 8.72 Hz; 
ArH), 3.92 (d, 2H, J = 5.88 Hz, OCH2), 2.64 (s, 6H, ArCH3), 1.79 (m, 1H, CH), 1.60-1.40 (m, 
s, 4H + 6H; CH2 + ArCH3), 1.36 (m, 4H; CH2), 0.96 (m, 6H, CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.2, 156.7, 145.8, 142.1, 132.1, 129.8, 126.8, 115.8, 
85.9, 71.2, 39.6, 31.0, 24.3, 17.6, 16.3, 14.3, 11.7. 
 
 
Synthesis of Compound S37: triethyleneglycol monomethyl ether (10 g, 61 mmol) was 
dissolved in 100 ml CH2Cl2 and 13 ml Et3N. In a dropper, p-toluene sulfonyl chloride (12 g, 
63 mmol) was dissolved in CH2Cl2 (20 ml) and was added to the previous solution dropwise 
while the reaction mixture was being cooled with ice bath. It was stirred for 12 h. After the 
extraction with water, organic layer was collected and dried with Na2SO4, evaporated under 
reduced pressure. (yellow oil, 55 mmol, 17.5 g, 90%). 
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1H NMR (CDCl3, 400 MHz, δ ppm) 7.78 (d, 2H; J = 8.24 Hz; ArH), 7.32 (d, 2H, J = 8.04 Hz; 
ArH) 4.15 (t, 2H; J = 4.77 Hz; OCH2), 3.67 (m, 4H; OCH2), 3.60 (m, 4H; OCH2), 3.51 (m, 
2H; OCH2). 3.34 (s, 3H; OCH3), 2.42 (s, 3H; ArCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 144.8, 133.0, 129.8, 127.9, 71.9, 70.7, 70.5, 70.5, 69.3, 
68.6, 59.0, 21.6.  
HRMS (TOF-ESI): m/z calcd for C14H22NaO6S+ 341.1029 [M+Na]+, found: 341.10639 
[M+Na]+, Δ = 10.23 ppm. 
 
Synthesis of Compound S38: methyl-3,4,5-trihydroxybenzoate (2.75 g, 15 mmol), compound 
S37 (15g, 47 mmol) and catalytic amount of benzo-18-crown-6 were dissolved in 60 ml 
acetone. K2CO3 (8.3 g, 60 mmol) were added and the reaction mixture was refluxed for 18 h.  
Then, solvent was removed under reduced pressure and the crude product was extracted with 
EtOAc and brine. Organic layer was dried with Na2SO4 and evaporated under reduced 
pressure. The product was purified by silica gel column chromatography using EtOAc as 
mobile phase. Fraction containing compound S38 was collected then the solvent was removed 
under reduced pressure (colorless liquid, 6 g, 9.6 mmol, 64%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.30 (s, 2H; ArH), 4.22 (m, 2H + 4H; OCH2), 3.88 (m, 
4H + 3H; OCH3 + OCH2), 3.80 (m, 2H; OCH2), 3.74 (m, 6H; OCH2). 3.65 (m, 12H; OCH2), 
3.56 (m, 6H; OCH2), 3.38 (s, 9H; OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 166.5, 152.3, 142.6, 124.9, 109.0, 72.4, 71.9, 70.8, 70.7, 
70.6, 70.5, 69.6, 68.8, 52.1.  
 
Synthesis of Compound S39: Compound S38 (3 g, 4.8 mmol) was dissolved in freshly 
distilled THF (20 ml) while rhe flask was being cooled within ice bath. To this solution, 
LiAlH4 (347 mg, 9.6 mmmol) was added portionwise. Then the reaction mixture was stirred 
12 h at RT. The excess LiAlH4 was carefully quenched with cold water and it was extracted 
with EtOAc and brine. Organic layer was dried with Na2SO4 and evaporated under reduced 
pressure. The product was purified by silica gel column chromatography using EtOAc as 
mobile phase. Fraction containing compound S39 was collected then the solvent was removed 
under reduced pressure (colorless liquid, 2.5 g, 4.2 mmol, 88%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 6.63 (s, 2H; ArH), 4.58 (s, 2H; OCH2), 4.15 (m, 2H + 
4H; OCH2), 3.84 (t, 4H, J = 5.29 Hz; OCH2), 3.79 (t, 2H, J = 5.44 Hz; OCH2), 3.73 (m, 6H; 
OCH2). 3.65 (m, 12H; OCH2), 3.54 (m, 6H; OCH2), 3.38 (s, 9H; OCH3). 
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13C NMR (CDCl3, 400 MHz, δ ppm) 152.7, 137.8, 136.7, 106.6, 72.3, 71.9, 70.8, 70.7, 70.5, 
69.8, 68.9, 65.2, 59.0.   
 
Synthesis of Compound S40: Compound S39 (2.4 g, 4 mmol) was dissolved in CH2Cl2 (25 
ml). Pyridinium chlorochromate (2.15 g, 10 mmol) was added to the reaction mixture and it 
was stirred for 40 min ar RT. Then, it was directly applied to silica column chromatography 
using EtOAc/MeOH (95/5; v/v) as mobile phase. Fraction containing compound S40 was 
collected then the solvent was removed under reduced pressure (colorless oil, 2.37 g, 
quantitative). 
1H NMR (CDCl3, 400 MHz, δ ppm) 9.82 (s, 1H), 7.14 (s, 2H; ArH), 4.21 (m, 6H; OCH2), 
3.89 (m, 4H; OCH2), 3.82 (m, 2H; OCH2), 3.80-3.50 (m, 24H; OCH2), 3.38 (s, 9H; OCH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 191.0, 153.0, 144.1, 131.6, 109.0, 72.5, 71.9, 70.8, 70.7, 
70.6, 70.5, 69.6, 68.9, 59.0.   
HRMS (TOF-ESI): m/z calcd for C28H48NaO13+ 615.2987 [M+Na]+, found: 615.28633 
[M+Na]+, Δ = 20.10 ppm. 
 
Synthesis of Compound S41: Compound S35 (100 mg, 0.14 mmol) was dissolved in 
tetrahydrofuran (30 ml) and triethylamine (5 ml). Argon was purged for 30 min. Then, 15% 
mole equivalent of Pd(PPh3)4 (24 mg, 21 µmol) was added. 4-(Tert-butyl)phenylacetylene (88 
µl, 0.49 mmol) was added via syringe and the reaction mixture was stirred 12 h at 60oC. After 
it was cooled to RT, it was extracted with CH2Cl2 and brine. Organic layer was dried with 
Na2SO4 and evaporated under reduced pressure. The product was purified by silica gel 
column chromatography using EtOAc/Hexanes (10/90; v/v) as mobile phase. Fraction 
containing compound S41 was collected then the solvent was removed under reduced pressure (92 
mg, 0.12 mmol, 86%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 7.43 (d, 4H, J = 8.16 Hz; ArH), 7.37 (d, 4H, j = 8.48 Hz; 
ArH), 7.18 (d, 2H, J = 8.52 Hz; ArH), 7.06 (d, 2H, J = 8.61 Hz; ArH), 3.95 (d, 2H, J = 5.76 
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Hz, OCH2), 2.73 (s, 6H, ArCH3), 1.80 (m, 1H, CH), 1.60-1.30 (m, 4H + 6H + 18H; CH2 + 
ArCH3 + CCH3), 0.96 (m, 6H, CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.3, 158.1, 151.4, 143.9, 142.7, 131.7, 131.1, 129.1, 
126.2, 125.4, 120.4, 116.2, 115.4, 96.5, 81.0, 70.9, 39.4, 34.8, 31.2, 30.6, 29.2, 23.9, 23.1, 
14.1, 13.7, 13.6, 11.2.  
HRMS (TOF-ESI): m/z calcd for C51H60BF2N2O+ 765.4761 [M+H]+, found: 765.4540 
[M+H]+, Δ = 28.87 ppm. 
 
Synthesis of Compound S42: Compound S41 (150 mg, 0.2 mmol) and compound S40 (100 
mg, 0.17 mmol) were dissolved in benzene (45 ml). Piperidine (0.3 ml) and acetic acid (0.3 
ml) were added. The reaction mixture was refluxed using Dean Stark apparatus until all 
aldehyde was consumed. After the reaction was completed, it was extracted with CH2Cl2 and 
water. Organic layer was collected and dried with Na2SO4, evaporated under reduced 
pressure. The product was purified by silica gel column chromatography using EtOAc/MeOH 
(85/15; v/v) as mobile phase. Fraction containing compound S42 was collected, then the 
solvent was removed under reduced pressure (41 µmol, 55 mg, 21%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.34 (d, 1H, J = 16.24 Hz; ArH), 7.62 (d, 1H, J = 16. 21 
Hz; ArH), 7.50-7.30 (m, 8H; ArH), 7.21 (d, 2H, J = 8.60 Hz; ArH), 7.06 (d, 2H, J = 8.65 Hz; 
ArH), 6.87 (s, 2H; ArH), 4.25 (m, 6H; OCH2), 3.95 (d, 2H, J = 4.56 Hz; OCH2), 3.90 (t, 4H, J 
= 5.37 Hz; OCH2), 3.85 (t, 2H, J = 4.40 Hz; OCH2), 3.80-3.50 (m, 24H; OCH2), 3.38 (s, 9H; 
OCH3), 2.77 (s, 3H; ArCH3), 1.8 (m, 1H; CH), 1.65 (s, 3H; ArCH3), 1.63 (s, 3H; ArCH3), 
1.60-1.40 (m, 6H; CH2), 1.40-1.20 (m, 18H + 2H; CH3 + CH2), 0.95 (m, 3H + 3H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.3, 152.9, 151.7, 151.5, 141.4, 140.0, 138.8, 132.5, 
131.1, 130.8, 129.3, 126.4, 125.5, 125.4, 120.5, 120.4, 115.4, 107.5, 98.1, 96.7, 83.3, 81.0, 
72.5, 72.0, 71.9, 71.0, 70.9, 70.7, 70.6, 69.8, 69.0, 59.0, 39.4, 34.8, 31.2, 30.6, 29.2, 23.9, 
23.0, 14.1, 13.7, 13.4, 11.2.  
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HRMS (TOF-ESI): m/z calcd for C79H105BF2N2NaO13+ 1361.7570 [M+Na]+, found: 
1361.7296 [M+Na]+, Δ = 20.12 ppm. 
 
Synthesis of Quencher Module, Q: Compound S42 (45 mg, 30 µmol) and 4-propargyloxy 
benzaldehyde  (9 mg, 56 µmol) were dissolved in benzene (25 ml). Piperidine (0.2 ml) and 
acetic acid (0.2 ml) were added. The reaction mixture was refluxed using Dean Stark 
apparatus until all aldehyde was consumed. After the reaction was completed, it was extracted 
with CH2Cl2 and water. Organic layer was collected and dried with Na2SO4, evaporated under 
reduced pressure. The product was purified by silica gel column chromatography using 
EtOAc/MeOH (90/10; v/v) as mobile phase. Fraction containing compound Q was collected, 
then the solvent was removed under reduced pressure (27 µmol, 40 mg, 90%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.49 (d, 1H, J = 16.24 Hz; ArH), 8.34 (d, 1H, J = 16.16 
Hz; ArH), 7.74 (d, 1H, J = 16.60 Hz; ArH), 7.65 (s + d + d, 1H + 2H + 2H; ArH), 7.50-7.30 
(m, 8H; ArH), 7.21 (d, 2H, J = 8.09 Hz; ArH), 7.10-7.00 (m, 2H + 2H; ArH), 6.90 (s, 2H; 
ArH), 4.77 (2H; OCH2), 4.25 (m, 6H; OCH2), 4.00- 3.50 (m, 32H; OCH2), 3.40 (s, 3H; 
OCH3), 3.37 (s, 6H; OCH3), 2.60 (1H; CH), 1.80-1.20 (m, 23H; CH3 + CH2), 0.98 (m, 3H + 
3H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.3, 158.6, 152.9, 151.7, 145.3, 140.2, 139.7, 138.8, 
132.7, 130.8, 130.7, 129.6, 129.2, 126.6, 125.6, 125.5, 120.6, 120.5, 115.3, 107.9, 98.4, 98.2, 
83.4, 83.1, 77.4, 77.1, 76.7, 75.9, 72.5, 72.0, 71.9, 69.9, 69.2, 59.0, 59.0, 59.0, 55.9, 39.4, 
34.8, 31.2, 30.6, 29.2, 23.9, 23.1, 14.1, 11.2. 
HRMS (TOF-ESI): m/z calcd for C89H111BF2N2NaO14+ 1503.7989 [M+Na]+, found: 
1503.7684 [M+Na]+, Δ = 20.28 ppm. 
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Synthesis of Compound S43: Compound Q (45 mg, 30 µmol) and compound S31 (62 mg, 
300 µmol) were dissolved in CH2Cl2 (6 ml) and MeOH (3 ml). Saturated solutions of 
CuSO4.5H2O (100 µl) and sodium ascorbate (100 µl) were added. Catalytic amount of Cu (0) 
was added. The reaction mixture was stirred for 12 h at room temperature. After the reaction 
was completed, it was extracted with CH2Cl2 and water. Organic layer was collected and 
dried with Na2SO4, evaporated under reduced pressure. The product was purified by silica gel 
column chromatography using EtOAc/MeOH (85/15; v/v) as mobile phase. Fraction 
containing compound S43 was collected, then the solvent was removed under reduced 
pressure (18 µmol, 30 mg, 60%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.48 (d, 1H, J = 16.32 Hz; ArH), 8.34 (d, 1H, J = 16.28 
Hz; ArH), 7.75-7.60 (d+ s + d + d, 2H + 1H + 1H + 2H; ArH), 7.50-7.30 (m, 8H; ArH), 7.21 
(d, 2H, J = 8.33 Hz; ArH), 7.08 (d, 2H, J = 3.49 Hz; ArH), 7.05 (d, 2H, J = 3.40 Hz; ArH), 
6.91 (s, 2H; ArH), 5.31 (s, 2H; OCH2), 4.73 (t, 2H, J = 6.64 Hz; NCH2), 4.25 (m, 6H; OCH2), 
4.00- 3.50 (m, 32H; OCH2), 3.40 (s, 3H; OCH3), 3.37 (s, 6H; OCH3), 3.22 (t, 2H, J = 6.64 Hz; 
NCH2), 2.89 (m, 2H + 2H; SCH2),  1.80-1.20 (m, 23H; CH3 + CH2), 0.98 (m, 3H + 3H; CH3). 
13C NMR (CDCl3, 400 MHz, δ ppm) 160.3, 159.3, 153.0, 151.8, 145.3, 144.4, 140.1, 139.6, 
138.9, 133.4, 132.7, 132.2, 131.9, 130.8, 130.4, 129.6, 128.6, 126.7, 125.5, 123.6, 120.6, 
118.4, 117.1, 116.1, 115.3, 114.0, 107.9, 107.2, 98.4, 98.2, 83.3, 72.5, 71.9, 70.9, 70.8, 70.7, 
70.5, 70.4, 69.8, 69.2, 68.9, 62.1, 59.0, 49.9, 48.9, 39.5, 37.7, 34.9, 31.3, 30.6, 29.2, 23.9, 
23.1, 14.1, 13.5.  
 
Synthesis of BOD 1: Compound S43 (40 mg, 24 µmol) and compound PS (45 mg, 37 µmol) 
were dissolved in CH2Cl2 (6 ml) and MeOH (3 ml). Saturated solutions of CuSO4.5H2O (100 
µl) and sodium ascorbate (100 µl) were added. Catalytic amount of Cu (0) was added. The 
reaction mixture was stirred for 12 h at room temperature. After the reaction was completed, it 
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was extracted with CH2Cl2 and water. Organic layer was collected and dried with Na2SO4, 
evaporated under reduced pressure. The product was purified by silica gel column 
chromatography using EtOAc/MeOH (85/15; v/v) as mobile phase. Fraction containing 
compound BOD 1 was collected, then the solvent was removed under reduced pressure (12 
µmol, 35 mg, 50%). 
1H NMR (CDCl3, 400 MHz, δ ppm) 8.48 (d, 1H, J = 15.92 Hz; ArH), 8.32 (d, 1H, J = 15.84 
Hz; ArH), 8.29 (s, 2H; ArH), 8.09 (d, J = 16.52 Hz, 2H; ArH), 7.95 (d, J = 8.04 Hz, 2H; ArH), 
7.8-7.5 (m, 10H; ArH), 7.50-7.30 (m, 10H; ArH), 7.25-7.10 (m, 6H; ArH), 7.10-7.0 (m, 5H; 
ArH), 6.90 (m, 6H; ArH), 5.30 (s, 2H, OCH2), 5.15 (s, 4H, OCH2), 4.65 (s, 4H, NCH2), 4.40 
(m, 2H, OCH2), 4.2 (m, 6H; OCH2), 4.10-3.50 (m, 36H, OCH2), 3.30 (s + s, 6H + 3H; OCH3), 
3.15 (m, 4H; SCH2), 2.05 (m, 18H; CH3), 1.8 (m, 4H), 1.60-1.0 (21H), 0.95 (m, 6H). 
13C NMR (CDCl3, 400 MHz, δ ppm) 167.8, 160.3, 160.2, 159.2, 158.6, 155.6, 152.8, 151.7, 
149.8, 146.6, 138.8, 136.2, 135.4, 133.7, 132.7, 130.8, 130.3, 129.6, 129.5, 129.4, 129.3, 
126.6, 125.6, 125.5, 124.4, 123.7, 120.7, 120.4, 119.4, 115.9, 115.8, 115.5, 115.3, 107.8, 72.4, 
71.9, 70.9, 70.8, 70.6, 70.5, 69.8, 69.1, 59.0, 58.9, 48.9, 40.6, 39.4, 31.2, 30.6, 30.2, 29.2, 
26.3, 25.6, 23.9, 23.0, 17.8, 14.1, 13.5, 11.2.  
HRMS (TOF-ESI): m/z calcd for C144H162B2F4I2N15O23S2- 2884.9 [M-H]-, found: 2884.9 [M-
H]. 
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